INSM

NASDAQ · Biotechnology

Insmed Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$129.38

+30.36 (+30.66%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 28 97%

Hold 1 3%

Sell 0 0%

Price Target

Analyst Price Target +10.8% upside

Low Target $91.17

Average Target $143.40

High Target $177.14

Current Price $129.38

Current
$129.38

Target
$143.40

$91.17 $143.40 avg $177.14

Scenario Analysis

Bear Case

$91.17

-29.5%

Low target

Base Case

$143.40

+10.8%

Avg target

Bull Case

$177.14

+36.9%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$212.75

-39.2% from high

52-Week Low

$90.39

+43.1% from low

50-Day SMA

$168.11

-23.0% vs SMA

200-Day SMA

$139.54

-7.3% vs SMA

RSI (14)

54.8

Neutral

Target vs 52W High

$143.40

-32.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%